SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001636050-22-000013
Filing Date
2022-02-07
Accepted
2022-02-07 19:17:01
Documents
2
Period of Report
2022-01-28

Document Format Files

Seq Description Document Type Size
1 FORM 3 wf-form3_164427940589383.html 3  
1 FORM 3 wf-form3_164427940589383.xml 3 13584
2 POA DOCUMENT MESWANI PARAG V. powerofattorney.htm EX-24 4105
  Complete submission text file 0001636050-22-000013.txt   19331
Mailing Address 130 WEST 42ND STREET 26TH FLOOR NEW YORK NY 10036
Business Address 130 WEST 42ND STREET 26TH FLOOR NEW YORK NY 10036 877-746-4891
Sio Gene Therapies Inc. (Issuer) CIK: 0001636050 (see all company filings)

IRS No.: 853863315 | Fiscal Year End: 0331
SIC: 2834 Pharmaceutical Preparations

Mailing Address 130 WEST 42ND STREET, 26TH FLOOR NEW YORK NY 10036
Business Address
Meswani Parag V (Reporting) CIK: 0001909324 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-37418 | Film No.: 22598911